Product
Oral
3 clinical trials
5 indications
Indication
Vestibular VertigoIndication
Vulvovaginal AtrophyIndication
Vasomotor SymptomsIndication
Atrial FibrillationIndication
Atrial flutterClinical trial
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 (80μg Estradiol/4mg Progesterone and 160μg Estradiol/8mg Progesterone Intravaginal Rings) in Healthy PostMenopausal WomenStatus: Completed, Estimated PCD: 2021-04-27
Clinical trial
Multicenter Randomized Controlled Phase 2 Trial to Evaluate AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery (TRAVERS)Status: Completed, Estimated PCD: 2022-03-28
Clinical trial
Emergency Department Atrial Fibrillation Oral Diltiazem Observation ProtocolStatus: Completed, Estimated PCD: 2023-04-01